pyrazole has been researched along with Anaplastic Astrocytoma in 2 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pyrazole compound 1 was further tested in a 10-dose IC(50) mode and showed an IC(50) value of 199 nM for ROS1 kinase." | 1.35 | Design, synthesis and biological evaluation of new potent and highly selective ROS1-tyrosine kinase inhibitor. ( Cho, SJ; El-Deeb, IM; Han, DK; Lee, HS; Lee, JY; Lee, SH; Oh, CH; Park, BS; Yoo, KH, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, BS | 1 |
| El-Deeb, IM | 1 |
| Yoo, KH | 1 |
| Oh, CH | 1 |
| Cho, SJ | 1 |
| Han, DK | 1 |
| Lee, HS | 1 |
| Lee, JY | 1 |
| Lee, SH | 1 |
| Shirakawa, H | 1 |
1 review available for pyrazole and Anaplastic Astrocytoma
| Article | Year |
|---|---|
[Pathophysiological significance of the canonical transient receptor potential (TRPC) subfamily in astrocyte activation].
Topics: Animals; Astrocytes; Astrocytoma; Biomarkers; Brain Injuries; Calcium; Calcium Signaling; Cell Proli | 2012 |
1 other study available for pyrazole and Anaplastic Astrocytoma
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of new potent and highly selective ROS1-tyrosine kinase inhibitor.
Topics: Antineoplastic Agents; Astrocytoma; Drug Design; Humans; Protein Kinase Inhibitors; Protein-Tyrosine | 2009 |